Clinical Trials Browser

Glioblastoma × liposomal doxorubicin × 90 days × Clear all

NCT05864534 2026-05-13

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Phase 2 Recruiting

Glioblastoma, Gliosarcoma